Dr. Jason Luke on Advances in How Melanoma is Diagnosed

November 3, 2015
Jason Luke, MD, FACP

Jason J. Luke, MD, FACP, assistant professor of medicine, The University of Chicago, discusses the international MSLT-II trial, which looks at the possibility of less surgery for melanoma patients in the future.

Jason J. Luke, MD, FACP, assistant professor of medicine, The University of Chicago, discusses the international MSLT-II trial, which looks at the possibility of less surgery for melanoma patients in the future.

Luke says the trial is investigating lymph nodes and how medical professionals are diagnosing tumors. He adds that while a lymph node may come up positive for melanoma, the test may only be showing one cancerous cell that could be taken out without as much surgery.